Krsnaa Diagnostics concludes 16th AGM in Pune on September 28

scanx
Reviewed by
Riya DScanX News Team
Key Highlights
  • Krsnaa Diagnostics held its 16th AGM on September 28, 2026
  • The meeting took place at the company's Pune registered office
  • Seven directors and three KMPs attended in person
  • 36 members participated via proxy or in person
powered bylight_fuzz_icon
52136319

*this image is generated using AI for illustrative purposes only.

Krsnaa Diagnostics Limited held its 16th Annual General Meeting (AGM) on Monday, September 28, 2026, at its registered office in Pune, Maharashtra. The meeting commenced at 11:00 am and concluded at 12:10 pm, attended by 36 members either in person or through authorised representatives.

The proceedings were chaired by Rajendra Mutha, Chairperson and Whole Time Director, who confirmed the requisite quorum. Sujoy Sudipta Bose, Company Secretary and Compliance Officer, welcomed the attendees and introduced the directors and key executives present on the dais.

Leadership and key personnel attendance

Seven directors were present in person at the venue, including the Managing Director and several independent directors overseeing critical committees such as Audit and Stakeholders Relationship. Key Managerial Personnel (KMPs) also attended the meeting.

Name Designation
Rajendra Mutha Chairperson and Whole Time Director
Yash Mutha Managing Director
Chetan Desai Independent Director and Chairperson of the Audit Committee
Adesh Kumar Gupta Independent Director and Chairperson of the Stakeholders Relationship Committee
Lilian Jessie Paul Independent Director
Raju Venkatraman Independent Director
Prem Pradeep Nominee Director

Key managerial personnel present

The following Key Managerial Personnel attended the meeting in person:

  • Mitesh Dave: Group Chief Executive Officer
  • Chandra Prakash Singh: Interim Chief Financial Officer
  • Sujoy Bose: Company Secretary and Compliance Officer

Auditor and scrutinizer representation

Representatives from the statutory auditor, secretarial auditor, and cost auditor firms were present to oversee the procedural aspects of the AGM.

Name Firm Designation
Ayush Bafna M/s MSKA and Associates, Chartered Accountant Senior Associate (Statutory Auditor)
Dinesh Birla M/s Dinesh Birla & Associates, Practicing Company Secretaries Proprietor (Secretarial Auditor and Scrutinizer)
Ashutosh Lende M/s Harshad S. Deshpande & Associates, Cost Accountants Authorised Representative of Cost Auditor (Special Invitee)

The company filed the summary of proceedings with stock exchanges pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Historical Stock Returns for Krsnaa Diagnostics

1 Day5 Days1 Month6 Months1 Year5 Years
-2.63%-1.31%-5.44%-6.91%-34.27%0.0%

How will the leadership transition to Managing Director Yash Mutha influence Krsnaa Diagnostics' strategic expansion plans in the coming fiscal year?

What specific governance reforms or operational efficiencies is Interim CFO Chandra Prakash Singh expected to implement during his tenure?

How might the recommendations from the Audit Committee under Chetan Desai impact the company's financial reporting standards and investor confidence?

Krsnaa Diagnostics shareholders approve preferential warrant issue to promoters

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights
  • Shareholders approved issuance of up to 16,21,000 convertible warrants to promoters
  • Resolution passed with 92.69% support from total votes polled
  • Promoter group voted 100% in favor, while 32.44% of institutions opposed
  • Total voting participation stood at 57.56% of outstanding shares
powered bylight_fuzz_icon
51294805

*this image is generated using AI for illustrative purposes only.

Krsnaa Diagnostics shareholders have approved the issuance of up to 16,21,000 warrants convertible into equity shares on a preferential basis to the promoter and promoter group.

The special resolution was passed on September 17, 2026, following a remote e-voting process conducted under Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The voting concluded at 5:00 pm IST, with Dinesh Birla & Associates appointed as the scrutinizer for the process.

Voting Results Breakdown

The resolution received overwhelming support from promoter shareholders while facing significant dissent from institutional investors. A total of 18,671,556 votes were polled out of 32,438,672 outstanding shares, representing a 57.56% participation rate.

Category Votes Polled In Favour Against Support %
Promoter Group 8,795,605 8,795,605 0 100.00%
Public Institutions 4,174,875 2,820,481 1,354,394 67.56%
Public Non-Institutions 5,701,076 5,690,485 10,591 99.81%
Total 18,671,556 17,306,571 13,64,985 92.69%

Promoter shareholders holding 8,795,605 shares voted unanimously in favor of the proposal. Among public non-institutional shareholders, who hold the largest share base of 17,712,796, support stood at 99.81%. However, institutional investors, holding 5,930,271 shares, showed notable resistance, with 32.44% voting against the resolution.

What the Numbers Show

The divergence in voting behavior highlights a clear split between retail/non-institutional public shareholders and institutional stakeholders. While the promoter group and retail investors backed the capital raise mechanism, nearly one-third of institutional votes opposed the preferential issuance. This suggests potential concerns among larger funds regarding dilution or valuation terms, despite the overall resolution passing with a comfortable majority of 92.69%.

Procedural Compliance

The postal ballot notice was issued on August 13, 2026, with voting commencing on August 18, 2026. The company circulated a corrigendum on August 28, 2026, allowing shareholders to modify prior votes; however, no modification requests were received by the scrutinizer. The process adhered to MCA circulars mandating electronic-only communication, with notices dispatched via email to registered members.

Historical Stock Returns for Krsnaa Diagnostics

1 Day5 Days1 Month6 Months1 Year5 Years
-2.63%-1.31%-5.44%-6.91%-34.27%0.0%

What specific valuation terms or conversion prices were attached to the warrants that likely triggered the 32.44% dissent from institutional investors?

How might the significant opposition from institutional shareholders impact Krsnaa Diagnostics' future ability to raise capital through preferential allotments?

Will the conversion of these 16.21 lakh warrants lead to material dilution for existing minority shareholders, and what is the projected timeline for this conversion?

More News on Krsnaa Diagnostics

1 Year Returns:-34.27%